Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Baxter International    BAX

BAXTER INTERNATIONAL (BAX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
74.3(c) 74.17(c) 73.33(c) 73.74(c) 74.32(c) Last
2 410 101 2 726 855 2 371 881 2 830 351 3 249 911 Volume
-1.22% -0.17% -1.13% +0.56% +0.79% Change
More quotes
Financials (USD)
Sales 2018 11 372 M
EBIT 2018 1 960 M
Net income 2018 1 517 M
Finance 2018 395 M
Yield 2018 0,95%
Sales 2019 11 902 M
EBIT 2019 2 252 M
Net income 2019 1 684 M
Finance 2019 657 M
Yield 2019 1,08%
P/E ratio 2018 27,47
P/E ratio 2019 24,28
EV / Sales2018 3,43x
EV / Sales2019 3,26x
Capitalization 39 437 M
More Financials
Company
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug... 
More about the company
Surperformance© ratings of Baxter International
Trading Rating : Investor Rating :
More Ratings
Latest news on BAXTER INTERNATIONAL
06/21BAXTER INTERNATIONAL : Patent Issued for Method for the Improvement of Mesh Impl..
AQ
06/14BAXTER INTERNATIONAL : Trademark Application for "BAXTER RENAL CARE SERVICES" Fi..
AQ
06/07BAXTER INTERNATIONAL : Unveiled Updates to SHARESOURCE Remote Patient Management..
AQ
05/31BAXTER INTERNATIONAL : Ex-dividend day for
FA
05/30BAXTER INTERNATIONAL : Supported Nine New Abstract Presentations at the 55th ERA..
BU
05/30BAXTER INTERNATIONAL : Unveiled Updates to SHARESOURCE Remote Patient Management..
BU
05/25BAXTER INTERNATIONAL : Announces U.S. FDA Clearance of New Spectrum IQ Infusion ..
AQ
05/25BAXTER INTERNATIONAL : Patent Issued for System and Method to Efficiently Clean ..
AQ
05/25BAXTER INTERNATIONAL : to Host 2018 Investor Conference
AQ
05/21BAXTER INTERNATIONAL : Highlights Business Strategies and Innovation at 2018 Inv..
BU
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06/18Baxter International Inc $BAX Given Average Rating of “Buy” by Analysts  
06/15Baxter International Inc $BAX Expected to Announce Earnings of $0.71 Per Shar.. 
06/15Baxter International Inc $BAX Expected to Post Quarterly Sales of $2.85 Billi.. 
06/15$BAX International Inc. Baxter International Inc. - March 2018 (LTM): Peer S.. 
06/14Baxter International $BAX Hits New 1-Year High and Low at $75.49  
More tweets
Qtime:97
News from SeekingAlpha
05/29Tracking Tweedy Browne Portfolio - Q1 2018 Update 
05/22Tracking Dan Loeb's Third Point Portfolio - Q1 2018 Update 
05/21Baxter bullish on growth strategy, ups earnings guidance 
05/18Key events next week - healthcare 
05/17Baxter Is Quickly Rebuilding Its Solid Dividend 
Chart BAXTER INTERNATIONAL
Duration : Period :
Baxter International Technical Analysis Chart | BAX | US0718131099 | 4-Traders
Technical analysis trends BAXTER INTERNATIONAL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 78,2 $
Spread / Average Target 6,1%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Vice President-Operations
James K. Saccaro Chief Financial Officer & Vice President
Paul E. Martin Chief Information Officer & Vice President
Sumant Ramachandra Chief Science & Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL14.74%39 889
MEDTRONIC PLC7.26%117 389
ALIGN TECHNOLOGY64.38%29 274
TERUMO CORP25.84%23 535
ZIMMER BIOMET HOLDINGS-7.11%22 728
HOYA CORPORATION10.78%21 630